Medifast, Inc. — FY2012 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended December 31, 2012; quarterly data below highlights Q4. Medifast manufactures and sells weight-management products through Take Shape For Life (TSFL), Medifast Direct, weight-control centers, and wholesale physician channels. Product sales represented 95% of annual revenue. At year-end, the company operated 87 corporate centers and had 35 franchise centers.
Financial performance
| Metric | FY2012 | FY2011 | Change |
|---|---|---|---|
| Revenue | $356.7 million | $298.2 million | +20% |
| Gross profit / margin | $268.0 million / 75.1% | $224.5 million / 75.3% | Margin down 0.2 percentage points |
| Operating income / margin | $23.3 million / 6.5% | $27.4 million / 9.2% | Income down 15% |
| Income before taxes | $24.5 million | $27.7 million | Down 12% |
| Net income | $15.9 million | $18.5 million | Down 14% |
| Diluted EPS | $1.16 | $1.31 | Down $0.15 |
| Cash from operations | $40.3 million | $34.9 million | Up $5.4 million |
| Capital expenditures | $11.4 million | $14.3 million | Down $2.9 million |
Q4 revenue was $83.2 million, up 20% from $69.6 million in Q4 2011. Gross profit was $62.8 million versus $52.3 million; pretax income was $3.6 million versus $1.5 million; net income was $1.9 million versus $1.2 million; and diluted EPS was $0.13 versus $0.08. Q4 revenue and net income were lower than Q3 2012, at $91.0 million and $7.2 million, respectively.
Liquidity and debt. Year-end cash and cash equivalents were $39.9 million, investment securities $20.1 million, and working capital $59.8 million. Total assets were $130.3 million and stockholders’ equity $90.8 million. Long-term debt was $3.3 million; capital lease liabilities were approximately $1.0 million. The company had an unused $5.0 million revolving credit line due to expire June 30, 2013. Debt and the credit line were secured by company assets and subject to financial covenants; the company reported compliance at year-end.
Material changes and operating drivers
- TSFL revenue rose 16% to $216.1 million, supported by more active Health Coaches (10,200 versus 9,600) and higher average monthly revenue per coach ($1,635 versus $1,555). TSFL generated 60.6% of total revenue.
- Medifast Direct revenue increased 16% to $84.4 million. Direct-response advertising spend was approximately $27.4 million; management reported a 3.0-to-1 return on advertising spend versus 2.8-to-1 in 2011.
- Weight Control Centers and Wholesale revenue rose 44% to $56.2 million. The company opened 19 corporate centers, closed two, and reported 12% same-store sales growth at centers open more than one year. The segment remained slightly unprofitable, with a $0.6 million pretax loss, improved from a $2.7 million loss.
- SG&A increased 24% to $244.8 million, rising to 68.6% of revenue from 66.1%. Higher commissions, staffing and growth-related costs contributed. Gross margin was broadly stable.
Outlook, commentary, risks, and unusual items
- Management forecast a 2013 effective tax rate of approximately 34%–35%; the filing does not provide clear revenue or earnings guidance.
- Reported 2012 results included a $3.7 million FTC civil penalty and a $3.3 million sales-tax accrual for prior-period exposure. The FTC consent decree requires changes to certain advertising claims and clinical-study protocols. Management’s non-GAAP adjusted figures exclude these items: adjusted operating income was $30.2 million, adjusted net income $21.6 million, and adjusted diluted EPS $1.57. These are company-presented non-GAAP measures, not GAAP results.
- A workforce reduction and staffing realignment generated $0.8 million in restructuring charges, fully paid by year-end; management cited approximately $3.0 million in annualized savings.
- Other material matters include pending shareholder derivative and securities class-action litigation, a company-initiated defamation action seeking $270 million, and an international licensing arrangement covering Mexico and planned expansion into additional Latin American markets in 2013. The filing does not establish the outcome or value of the pending litigation.
- Key risks include dependence on advertising effectiveness and the TSFL coach network, advertising and product-claim regulation, customer health and product-liability claims, reliance on third-party manufacturing and raw materials, competition and changing consumer preferences, and execution of center and international growth. The company also noted variable-rate debt exposure; a 100-basis-point rate increase would raise annual interest expense by about $33,000 on year-end variable-rate borrowings.
- The company reported effective disclosure controls and internal control over financial reporting; the auditor issued unqualified opinions on the financial statements and internal controls.
Important facts for investors to verify
- Whether reported growth and coach productivity remain sustainable, given TSFL’s concentration in revenue.
- How the FTC consent decree affects future advertising, substantiation requirements, and customer acquisition costs.
- The final amount and timing of sales-tax settlements with states compared with the $3.3 million accrual.
- Progress toward profitability in the expanding centers channel and the returns on its lease and capital investments.
- Renewal or replacement of the $5.0 million credit line before its June 30, 2013 expiration, and the status of pending litigation.